REACTIVE CARBONYL SPECIES AND CEREBRAL MICROVASCULAR DISEASES

反应性羰基物质与脑微血管疾病

• 批准号: 7960365
• 负责人: KESHORE R BIDASEE
• 金额: $ 5.62万
• 依托单位: UNIVERSITY OF NEBRASKA LINCOLN
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-08-01 至 2010-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7960365
• 关键词: Alzheimer' s Disease; Biology; Blood - brain barrier anatomy; Blood Glucose; Brain; Brain Injuries; Cardiovascular Diseases; Caring; Cell physiology; Cerebrum; Chronic; Computer Retrieval of Information on Scientific Projects Database; Coupling; Data; Defect; Diabetes Mellitus; Diabetic Angiopathies; Endothelial Cells; Funding; General Population; Grant; Impaired cognition; In Vitro; Incidence; Individual; Institution; Laboratories; Molecular; Oxidants; Oxidation-Reduction; Permeability; Quality of life; Research; Research Personnel; Resources; Source; Stroke; Time; United States National Institutes of Health; Work; artery occlusion; base; blood glucose regulation; cerebral artery; diabetic patient; economic cost; high risk; improved; in vivo; insight; nervous system disorder; novel therapeutics; stem

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Individuals with diabetes mellitus (DM) have cerebral microvascular diseases including ischemic and lacunar strokes at rates three to five times higher than that of the general population. The extent of brain damage following a stroke is also aggravated in these individuals. Even more troubling, are the observations that diabetic patients who have tight blood glucose control still develop cognitive impairment and are at a higher risk of developing spontaneous Alzheimer's disease. Recent studies suggest that these defects stem in part from an increase in blood-brain-barrier (BBB) permeability. What remain elusive are the molecular triggers responsible for initiating BBB breach. Exciting new data emerging from our laboratory as well as a few others indicate that reactive carbonyl species (RCS) generated during diabetes may be one of these triggers. Our working hypothesis is that "RCS generated during diabetes interact with and compromise the function of endothelial cells resulting in BBB breach and increased incidence of Neurological disorders." We will use in vitro studies to elucidate mechanisms by which RCS compromise brain endothelial cell function and in vivo studies to show that chronic elevation of RCS leads to blood brain barrier breach and an increase in cerebral damage following cerebral artery occlusion. The proposed research will provide data in support of the concept of "RCS-ROC coupling." It will also provide mechanistic insights into how this group of understudied cellular oxidants impairs endothelial cell function leading to incrased BBB permeability, the basis for a direction of an R01 application. More globally, data from the proposed research could also be useful for developing newer therapeutic strategies to slow the progression of cardiovascular diseases during diabetes, improve the quality of life of diabetic patients and control the escalating economic cost of diabetes care, which is estimated to be in excess of $132 billion annually.

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 中心，但不一定是研究者所在的机构。 糖尿病（DM）患者患有脑微血管疾病，包括缺血性和腔隙性中风，其发病率比普通人群高3至5倍。 中风后的脑损伤程度在这些人中也会加重。 更令人不安的是，观察到血糖控制严格的糖尿病患者仍然会出现认知障碍，并且患自发性阿尔茨海默病的风险更高。 最近的研究表明，这些缺陷部分源于血脑屏障（BBB）通透性的增加。 仍然难以捉摸的是负责启动BBB破坏的分子触发因素。 从我们的实验室以及其他一些实验室中出现的令人兴奋的新数据表明，糖尿病期间产生的反应性羰基物质（RCS）可能是这些触发因素之一。 我们的工作假设是“糖尿病期间产生的RCS与内皮细胞相互作用并损害内皮细胞的功能，导致BBB破坏和神经系统疾病的发病率增加。“我们将使用体外研究来阐明RCS损害脑内皮细胞功能的机制，并使用体内研究来表明RCS的慢性升高导致血脑屏障破坏和脑动脉闭塞后脑损伤的增加。 本研究将为“RCS-ROC耦合”的概念提供数据支持。“它还将提供关于这组未充分研究的细胞氧化剂如何损害内皮细胞功能导致BBB渗透性增加的机制见解，这是R 01应用方向的基础。 在全球范围内，拟议研究的数据也可能有助于开发新的治疗策略，以减缓糖尿病期间心血管疾病的进展，改善糖尿病患者的生活质量，并控制糖尿病护理不断上升的经济成本，估计每年超过1320亿美元。